Neurobiologische Aspekte zur Ätiologie und Pathophysiologie der Zwangsstörung

Zusammenfassung

Die Zwangsstörung ist mit einer Prävalenz von 1 - 2 % eine häufige psychiatrische Erkrankung. Sie ist durch wiederkehrende Gedanken, Ideen und/oder wiederholt ablaufende Verhaltensweisen charakterisiert, die den Betroffenen erheblich belasten. Im letzten Jahrzehnt wurden unterschiedliche Modelle zur Pathophysiologie der Zwangsstörung entwickelt. In diesem Artikel werden drei verschiedene neurobiologische Modelle vorgestellt: 1. Modell der dysfunktionalen kortikostriatalen Regelkreise, 2. die zentrale Rolle der Amygdala, 3. neurochemisch-serotonerges Modell. Diese Modelle schließen sich nicht gegenseitig aus, sondern ergänzen sich und sollten am besten in ein biopsychosoziales Gesamtkonzept integriert werden. Die Erkenntnisse aus der Neurobiologie haben unmittelbare Auswirkungen auf die Weiterentwicklung von Diagnostik und Therapie der Zwangsstörung.

Neurobiological Aspects of the Etiology and Pathophysiology of Obsessive-Compulsive Disorders

Obsessive-compulsive disorder (OCD) is a common psychiatric illness characterized by intrusive, repetitive thoughts and behaviours which cause marked distress. During the last decade, different models were developed for the pathophysiology of the obsessive-compulsive-disorder. Three different neurobiological models are introduced in this article: 1. model of dysfunctional kortikostriatal circuitry, 2. amygdalocentric model, 3. neurochemical model. These models don't exclude themselves mutually but supplement themselves and should ideally be integrated into a bio-psycho-social concept. Such increased understanding of the neurobiology can be translated into better diagnosis and treatment for those patients who suffer from obsessive-compulsive-disorder.

Obsessive-compulsive-disorder - Neurobiology - Pathophysiology

Literatur

• 1 Reinecker H S. Zwänge - Diagnose, Theorie und Behandlung. Bern, Göttingen, Toronto, Seattle; Hans Huber 1998
• 2 McKeon J, McGuffin P, Robinson P. Obsessive-compulsive neurosis following head injury.  Brit J Psychiat. 1984;  144 190-192
• 3 Ebert D, Glötzner F L, Thron S. Zwangssyndrom und Epilepsie - Kasuistik und Literaturdurchsicht.  Fundamenta Psychiatrica. 1990;  4 186-189
• 4 Kettle P A, Marks I M. Neurological factors in OCD: two case reports and a review of the literature.  Brit J Psychiat. 1986;  149 315-319
• 5 Capstick N, Seldrup J. Obsessional states.  Acta Psychiat Scand. 1977;  56 427-431
• 6 Denckla M B. The neurological examination. In: Rapoport Jl (ed) OCD in children and adolescents. Washington DC; Am Psychiatric Pres 1989: 107-118
• 7 Hollander E, Schifmann E, Cohen B. et al . Signa of central nervous system dysfunction in OCD.  Arch Gen Psychiatry. 1990;  47 27-32
• 8 Stein D J, Hollander E, Chan S. et al . Computed tomography and neurological soft signs in OCD.  Psychiat Res Neuroimaging. 1993;  5 143-150
• 9 Müller N, Straub A, Horn B. et al . Zwänge als Leitsymptom des GTS: Ein Beitrag zur Differenzialdiagnose des Zwangssymptoms.  Nervenheilkunde. 1988;  7 226-232
• 10 Pauls L P, Towbin K E, Leckmann J F. et al . GTS and OCD.  Arch Gen Psychiat. 1986;  43 1180-1182
• 11 Steingard R, Dillon-Stout D. Tourette's syndrome and OCD. Clinical aspects.  Psych Clin North America. 1992;  15 849-860
• 12 Husby G, van de Rijn I, Zabriskie J B. et al . Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever.  J Exp Med. 1976;  144 1094-1110
• 13 Swedo S E, Rapoport J L, Cheslow D L. et al . High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea.  Am J Psychiatry. 1989;  146 246-249
• 14 Rauch S L, Savage C R, Alpert N M. et al . The functional neuroanatomy of anxiety: a study of three disorders using PET and symptom provocation.  Biol Psychiatry. 1997;  42 446-452
• 15 Alexander G E, DeLong M R, Strick P L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex.  Annual Review of Neuroscience. 1986;  9 357-381
• 16 Alexander G E, Crutcher M D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing.  TINS. 1990;  13 266-271
• 17 Graybiel A M. Building action repertoires: memory and learning functions of the basal ganglia.  Curr Opin Neurobiol. 1995;  5 733-41
• 18 Houk J C, Davis J L, Beiser  D G. (eds) .Models of information pro-cessing in basal ganglia. Cambrigde; MIT Press 1995
• 19 Rauch S L, Paul J W, Dougherty D, Jenike M A. Neurobiologic models of ocd. In: Jenike MA, Baer L, Minichiello WE (eds) Obsessive-compulsive disorder Theory and management, ed. 3. Chicago; Mosby 1998
• 20 Graybiel A M. Neurotransmitters and neuromodulators in the basal ganglia.  TINS. 1990;  13 244-254
• 21 Kordon A, Hohagen F. Die Neurobiologie der Zwangsstörung.  Psychotherapie. 1998;  3 177-185
• 22 Savage R C. Neuropsychology of obsessive-compulsive disorder: Research findings and treatment implications. In: Jenike MA, Baer L, Minichiello WE (eds) Obsessive-compulsive disorder: Theory and management, ed. 3. Chicago; Mosby 1998
• 23 Schmidtke K, Schorb A, Winkelmann G, Hohagen F. Cognitive frontal lobe dysfunction in obsessive-compulsive disorder.  Biol Psychiatry. 1998;  43 666-73
• 24 Jenike M A. Neurosurgical treatment of obsessive-compulsive disorder.  Br J Psychiatry. 1998;  173, Suppl 35 79-90
• 25 Insel T R. Toward a neuroanatomy of obsessive-compulsive disorder.  Arch Gen Psychiatry. 1992;  49 739-744
• 26 Baxter L R, Schwartz J M, Bergmann K S. et al . Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder.  Arch Gen Psychiatry. 1992;  49 681-689
• 27 Rauch S L, Jenike M A. Neurobiological models of obsessive-compulsive disorder.  Psychosomatics. 1993;  34 20-32
• 28 Modell J, Mountz J, Curtis G. et al . Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanismen of ocd.  J Neuropsychiatry. 1989;  1 27-36
• 29 Baxter L R, Schwartz J M, Guze B H. et al .Neuroimaging in ocd: seeking the mediating euroanatomy. In: Jenike MA, Baer L, Minichiello WE (eds) Obsessive-compulsive disorder: Theory and management, ed. 2. Chicago; Mosby 1990
• 30 Saxena S, Brody A L, Schwartz J M, Baxter L R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder.  Br J Psychiatry. 1998;  173, Suppl 35 26-37
• 31 Rauch S L, Jenike M A. Neural mechanisms of obsessive-compulsive disorder.  Curr Rev Mood Anx Dis. 1997;  1 84-94
• 32 Breiter H C, Rauch S L, Kwong K K. et al . Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder.  Arch Gen Psychiatry. 1996;  49 595-606
• 33 Ungerleider L G. Functional brain imaging studies of cortical mechanisms for memory.  Science. 1995;  27 769-775
• 34 Schacter D L, Alpert N M, Savage C R. Conscious recollection and the human hippocampal formation: evidence from positron emission tomography.  Proc Natl Acad Sci USA. 1996;  93 321-325
• 35 Rauch S L, Savage C R, Brown H D. et al . A PET investigation of implicit and explicit sequence learning.  Hum Brain Mapping. 1995;  3 271-286
• 36 Mishkin M, Petri H L. Memory and habits: some implications for the analysis of learning and retention. In: Squire LR, Butters N (eds) Neuropsychology of memory. New York; Guilford Press 1984
• 37 Kapp B S, Whalen P J, Supple W F. Amygdaloid contributions to conditioned arousal and sensory information processing. In: Aggleton JP (eds) The amygdala: neurobiological aspects of emotion, memory and mental dysfunction. New York; Wiley-Liss 1992
• 38 LeDoux J E. Emotion, memory and the brain.  Sci Am. 1994;  27 32-39
• 39 Davis M. The role of amygdala in conditioned fear. In: Aggleton JP (ed) The amygdala: neurobiological aspects of emotion, memory and mental dysfunction. New York; Wiley-Liss 1992
• 40 LeDoux J E. The emotional brain. New York; Simon and Schuster 1996
• 41 Amaral D G, Price J L, Pitkanen A. Anatomical organization of the primate amygdala. In: Aggleton JP (ed) The amygdala: neurobiological aspects of emotion, memory and mental dysfunction. New York; Wiley-Liss 1992
• 42 Mowrer O H. A stimulus-response analysis of anxiety and its role as a reinforcing agent.  Psychol Rev. 1939;  46 553-565
• 43 Miller N E. Studies of fear as an acquirable drive: I. Fear as motivation and fear reduction as reinforcement in the learning of new responses.  J Exper Psychol. 1948;  38 89-101
• 44 Morgan M A, Romanski L, LeDoux J E. Extinction of emotional learning: contribution of medial prefrontal cortex.  Neurosci Lett. 1993;  163 109-113
• 45 Morgan M A, LeDoux J E. Differential contribution of dorsal and ventral medial prefrontal cortex to acquisition and extinction of conditioned fear in rats.  Behav Neurosci. 1995;  109 681-688
• 46 Sanders S K, Shekar A. Anxiolytic effects of chlordiazepoxide blocked by injection of GABA A and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats.  Biol Psychiatry. 1995;  37 473-476
• 47 Thoren P, Asberg M, Cronholm B. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.  Arch Gen Psychiatry. 1980;  37 1282-1285
• 48 Thoren P, Asberg M, Cronholm B. Clomipramine treatment of obsessive-compulsive disorder. II. A controlled clinical trial.  Arch Gen Psychiatry. 1980;  37 1286-1294
• 49 Greist J H, Jefferson J W. Pharmacotherapy of obsessive-compulsive disorder.  Br J Psychiatry. 1998;  173, Suppl 35 64-70
• 50 Barr L C, Goodmann W K, Price L H. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.  J Clin Psychiatry. 1992;  53, Suppl 17-28
• 51 Gross-Isseroff R, Kindler S, Kotler M. Pharmacologic challenges. In: Berend B, Hollander E, Marazziti D, Zohar J (eds) Current insights in obsessive-compulsive disorder. Chichester; J Wiley 1994
• 52 Blier P, de Montigny C. Current advances and trends in the treatment of depression.  Trends Pharmacol Sci. 1994;  15 220-226
• 53 Blier P, Bouchard C. Modulation of 5 HT release in the guines pig brain following long-term administration of antidepressant drugs.  Br J Pharmacol. 1994;  113 485-495
• 54 Mansari M E, Bouchard C, Blier P. Alteration of serotonin release in the guines pig orbito-frontal cortex by selective serotonin reuptake inhibitors.  Neuropsychopharmacology. 1995;  13 117-127
• 55 Mc Dougle C J, Goodmann W K, Price L H. Neuroleptic addition in fluvoxamine refractory obsessive-compulsive disorder.  Am J Psychiatry. 1990;  147 652-654
• 56 Schwartz J. Zwangshandlungen und wie man sich davon befreit. Frankfurt; Krüger 1997